HLB bioStep Co.,Ltd. (KOSDAQ:278650)
1,518.00
+9.00 (0.60%)
At close: Dec 5, 2025
HLB bioStep Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 128,226 | 176,390 | 242,875 | 327,966 | 219,226 | 191,246 | Upgrade
|
| Market Cap Growth | -25.35% | -27.37% | -25.95% | 49.60% | 14.63% | 27.19% | Upgrade
|
| Enterprise Value | 139,531 | 168,104 | 226,210 | 341,037 | 227,757 | 189,762 | Upgrade
|
| Last Close Price | 1518.00 | 2095.00 | 3090.00 | 4650.00 | 3169.24 | 2756.75 | Upgrade
|
| PE Ratio | - | - | - | - | 19.87 | 23.04 | Upgrade
|
| PS Ratio | 1.79 | 3.03 | 4.60 | 3.80 | 3.40 | 3.27 | Upgrade
|
| PB Ratio | 1.14 | 1.51 | 2.35 | 4.54 | 3.30 | 3.48 | Upgrade
|
| P/TBV Ratio | 1.30 | 1.73 | 2.43 | 4.79 | 3.50 | 3.70 | Upgrade
|
| P/FCF Ratio | - | - | 204.19 | 206.70 | - | 25.44 | Upgrade
|
| P/OCF Ratio | - | - | 46.78 | 50.61 | 25.90 | 16.68 | Upgrade
|
| EV/Sales Ratio | 1.95 | 2.89 | 4.28 | 3.95 | 3.54 | 3.24 | Upgrade
|
| EV/EBITDA Ratio | - | - | 98.80 | 36.23 | 18.93 | 20.86 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 64.24 | 25.29 | 26.96 | Upgrade
|
| EV/FCF Ratio | -7.65 | - | 190.18 | 214.94 | - | 25.25 | Upgrade
|
| Debt / Equity Ratio | 0.27 | 0.30 | 0.59 | 1.27 | 0.25 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 26.48 | 9.74 | 1.35 | 0.83 | Upgrade
|
| Debt / FCF Ratio | - | - | 50.98 | 57.76 | - | 1.00 | Upgrade
|
| Asset Turnover | 0.44 | 0.34 | 0.31 | 0.65 | 0.76 | 0.86 | Upgrade
|
| Inventory Turnover | 12.19 | 11.33 | 10.96 | 14.15 | 8.80 | 9.20 | Upgrade
|
| Quick Ratio | 0.75 | 1.20 | 1.15 | 8.36 | 1.14 | 1.45 | Upgrade
|
| Current Ratio | 1.29 | 1.35 | 1.23 | 8.57 | 1.75 | 1.86 | Upgrade
|
| Return on Equity (ROE) | -7.84% | -8.80% | -0.06% | -1.27% | 19.00% | 17.28% | Upgrade
|
| Return on Assets (ROA) | -4.24% | -4.80% | -0.43% | 2.49% | 6.67% | 6.48% | Upgrade
|
| Return on Capital (ROIC) | -4.66% | -5.17% | -0.45% | 2.69% | 7.75% | 7.73% | Upgrade
|
| Return on Capital Employed (ROCE) | -9.40% | -10.70% | -1.10% | 3.30% | 11.50% | 12.00% | Upgrade
|
| Earnings Yield | -6.00% | -4.86% | -0.07% | -0.31% | 5.03% | 4.34% | Upgrade
|
| FCF Yield | -14.23% | -11.68% | 0.49% | 0.48% | -5.08% | 3.93% | Upgrade
|
| Payout Ratio | - | - | - | - | 10.26% | - | Upgrade
|
| Buyback Yield / Dilution | 8.09% | -11.80% | -9.59% | -0.02% | -1.35% | -13.51% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.